SeaSpine (Nasdaq: SPNE), a $154m developer of orthobiologics and spinal implant solutions is paying $110m to buy Canada-based 7D Surgical, the producer of a machine-vision, image-guided surgery platform with applications in spine and cranial surgeries. 7D’s system reduces radiation exposure by eliminating intra-operative CT (computed tomography) and fluoroscopy for purposes of registration, both commonly used with traditional navigational systems. In February 2020, SeaSpine entered into a strategic alliance to distribute 7D Surgical’s system.
Keywords: Healthcare Investment Banking, Healthcare M&A, Healthcare Mergers, Medical Devices, Spine